SAN DIEGO–Illumina, Inc. (NASDAQ:ILMN – News) today announced that GeneSeek Inc., a leading provider of genotyping services for agribusiness, is the first organization focusing on this key research community to become an Illumina CSPro® (certified service provider). Illumina CSPro is a collaborative service provider partnership dedicated to ensuring delivery of the highest-quality data available for […]
Second Phase to Analyze the Genetic Information of 36,000 Additional Individuals to Better Understand Seven New Common Disorders SANTA CLARA, Calif.–Affymetrix, Inc. (Nasdaq:AFFX – News) today announced that the Wellcome Trust of Great Britain has awarded to Affymetrix the second phase of its Case Control Consortium (WTCCC) project, the world’s largest-ever study of the genetics […]
SAN DIEGO–Illumina, Inc. (NASDAQ:ILMN – News) today announced the appointment of Stephen Pentoney as Vice President of Array Biochemistry reporting to Joel McComb, Senior Vice President and General Manager of Illumina’s Life Sciences Business Unit. In Stephen’s new role, he is responsible for leading Illumina’s assay and application development efforts. Prior to joining Illumina, Stephen […]
Burgess Hill, UK, 17.07.2008 – Roche Diagnostics Ltd. today announced that they will support the Oxford Biomedical Research Centre (OxBRC) – a partnership between the Oxford Radcliffe Hospitals NHS Trust and University of Oxford – in the development of solutions enabling improved genetic and cytogenetic testing. Using the next-generation sequencing technology of 454 Sequencing and […]
Patent Family Comprises Complementary Technologies That Enable Predictive Whole Genome Association Studies MOUNTAIN VIEW, Calif.–Perlegen Sciences, Inc., a molecular diagnostics company focused on the discovery and commercialization of clinically important human genetic variation, announced today the opening of its portfolio of patented technologies that together enable whole genome association studies capable of assessing an individual’s […]
GAITHERSBURG, MD and SANTA CLARA, Calif., July 14, 2008 —Gene Logic (An Ocimum Biosolutions Company) and Agilent Technologies today announced that Gene Logic has been reappointed as a Certified Microarray Service Provider for Agilent gene expression microarrays. The Certified Service Provider (CSP) program comprises a select list of strategic organizations that pass a rigorous assessment […]
PENZBERG, Germany–The Cancer Genomics Group at Barts and The London Medical School is researching leukemia with the aquisition of the state-of-the-art Genome Sequencer FLX System paired with the Roche NimbleGen Sequence Capture arrays. Researchers, led by Professor Brian Young, will use the combined technology of 454 Sequencing and NimbleGen Sequence Capture Arrays to uncover the […]
Reagent Kits Will Strengthen Affymetrix’ Diagnostic Product Portfolio SANTA CLARA, Calif. & AUSTIN, Texas–Affymetrix Inc. (NASDAQ:AFFX – News) and Asuragen Inc., a leading molecular biology diagnostic company and service provider, today announced an agreement to license, develop and manufacture in vitro transcription (IVT) reagent kits for clinical molecular diagnostic applications. The new IVT reagent kits […]
ST. JOSEPH, Mich., July 8 — GeneGo, Inc., the leading systems biology tools company, announced today that Keck Microarray Center at Yale has become a certified GeneGo Center of Excellence (COE). Yale researchers will have access to GeneGo’s MetaCore, training and advanced support. The W. M. Keck Foundation Biotechnology Resource Laboratory (Keck Lab), one of […]
SAN DIEGO–Illumina, Inc. (NASDAQ:ILMN – News) today announced that researchers participating in a new initiative funded by the Wellcome Trust selected Illumina’s Infinium HD BeadChips to analyze 90,000 DNA samples. This new initiative aims to decipher the molecular basis of human disease and includes participation from leading research groups around the globe. Together, researchers at […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
